CASI Pharmaceuticals Inc (NASDAQ:CASI)
| 2.82 Delayed Data As of 3:59pm ET |  +0.14 / +5.22%Today’s Change | 2.24 Today|||52-Week Range 12.40 | -64.75% Year-to-Date |
Latest CASI News | Press Releases
No recent news for CASI Pharmaceuticals Inc.
Today’s Trading
| Previous close | 2.68 |
| Today’s open | 2.90 |
| Day’s range | 2.78 - 2.90 |
| Volume | 131 |
| Average volume (3 months) | 186,079 |
| Market cap | $37.1M |
Data as of 3:59pm ET, 10/04/2022
Growth & Valuation
| Earnings growth (last year) | +38.40% |
| Earnings growth (this year) | +50.62% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +100.12% |
| P/E ratio | NM |
| Price/Sales | 3.63 |
| Price/Book | 0.45 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BYSIBeyondspring Inc | +0.01 | +1.08% |
| ---- | ||
| TCONTRACON Pharmaceutica... | +0.04 | +2.38% |
| --Newron Pharmaceutica... | 0.00 | 0.00% |
Data as of 4:00pm ET, 10/04/2022
Financials
| Next reporting date | November 15, 2022 |
| EPS forecast (this quarter) | -$0.46 |
| Annual revenue (last year) | $30.0M |
| Annual profit (last year) | -$36.7M |
| Net profit margin | -122.10% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
